期刊
CARBOHYDRATE POLYMERS
卷 273, 期 -, 页码 -出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.carbpol.2021.118605
关键词
Chitosan; Nanoparticles; Diethylaminoethyl; Pneumococcus; Enzybiotics
资金
- Ministerio de Economia y Competitividad (MINECO-FEDER) [SAF2017-88664-R]
- Ministerio de Ciencia e Innovacion [MAT2017-84277-R, PID2019-105126RBI00]
- CONACyT (Mexico)
- Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias (CIBERES)
- Biomateriales y Nanomedicina (CIBER-BBN), an initiative of the Instituto de Salud Carlos III
- CIBERES
- CSIC
Advanced biomaterials like chitosan derivatized nanoparticles (ChiDENPs) show potential for combating bacterial infections. ChiDENPs were synthesized to imitate choline residues in pneumococcal cell walls as ligands for choline-binding proteins (CBPs). This platform successfully encapsulated the antimicrobial enzyme Cpl-711 and demonstrated controlled release in biological settings.
Advanced biomaterials provide an interesting and versatile platform to implement new and more effective strategies to fight bacterial infections. Chitosan is one of these biopolymers and possesses relevant features for biomedical applications. Here we synthesized nanoparticles of chitosan derivatized with diethylaminoethyl groups (ChiDENPs) to emulate the choline residues in the pneumococcal cell wall and act as ligands for cholinebinding proteins (CBPs). Firstly, we assessed the ability of diethylaminoethyl (DEAE) to sequester the CBPs present in the bacterial surface, thus promoting chain formation. Secondly, the CBP-binding ability of ChiDENPs was purposed to encapsulate a bio-active molecule, the antimicrobial enzyme Cpl-711 (ChiDENPs-711), with improved stability over non-derivatized chitosan. The enzyme-loaded system released more than 90% of the active enzybiotic in approximate to 2 h, above the usual in vivo half-life of this kind of enzymes. Therefore, ChiDENPs provide a promising platform for the controlled release of CBP-enzybiotics in biological contexts.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据